Status: Recruiting
A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patients With Dravet Syndrome
The purpose of the study is to evaluate the efficacy, safety, and tolerability of zorevunersen in Patients with Dravet syndrome.
Participants needed: 170
Trial details
Phase: Phase 3Age: 2-17Biological sex: AllType: InterventionalSponsor: Stoke Therapeutics, IncUpdated: Jul 1, 2026Locations: 58
Eligibility criteria
Patients must be ≥2 and <18 years of age. [+5]
Patient has documented variant in the SCN1A gene associated with gain-of-functio... [+3]